Conditions: Type 2 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 86
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if MSDC-0160 is effective in the treatment of Type 2 diabetes.

Detailed description:

Arms:
arm 1: Microcrystaline cellulose once daily arm 2: Pioglitazone 45 mg once daily arm 3: MSDC-0160 90 mg once daily arm 4: MSDC-0160 220 mg once daily

Interventions: intervention 1: Placebo intervention 2: Pioglitazone intervention 3: MSDC-0160 90 mg intervention 4: MSDC-0160 220 mg
Intervention descriptions: intervention 1: Once daily, oral intervention 2: Once daily, oral intervention 3: Once daily, oral intervention 4: Once daily, oral

Protocol document: